| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_204ea9f0f83d1c51a916e46a41a6a14a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-899 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-465 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D305-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07G99-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335 |
| filingDate |
1978-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1981-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fef8c9cb766bafd47f19c127ed69696
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6e8323bfadb9a8d977d0f7712a0cabc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e64ec98f25d3ea77375c01b51747f7dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d691171c348fa34778e2c3282d15f607
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92b5dbdbb2968008aeb158620c8ee760 |
| publicationDate |
1981-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-1113411-A |
| titleOfInvention |
Physiologically active substance esterastin and production thereof |
| abstract |
ABSTRACT OF THE DISCLOSURE A new physiologically active substance named esterastin is now provided, which inhibits the activity of esterase and is useful as an immunosuppressive drug. Esterastin is produced by cultivating a micro-organism Streptomyces MD4-C1 identified as FERM-P 3723 or ATCC. 31336 in a culture medium under aerobic conditions and recovering it from the resulting culture. Esterastin is the compound having the formula . |
| priorityDate |
1977-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |